ZB022
Autoimmune Disease
Not DisclosedInvestigational
Key Facts
About Zenas BioPharma
Zenas BioPharma is a global biopharmaceutical company with a mission to become a leader in autoimmune disease therapies, enabling patients to 'reimagine life.' Led by a veteran team with a proven track record, the company is advancing a pipeline anchored by two late-stage investigational drugs with broad potential across multiple autoimmune indications. Their strategy combines internal development with strategic partnerships and is guided by a set of core values emphasizing transparency, urgency, and innovation.
View full company profileTherapeutic Areas
Other Autoimmune Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| ZB021 | Zenas BioPharma | Not Disclosed |
| Plonmarlimab | Xencor | Clinical |
| ALLO-329 | Allogene Therapeutics | Phase 1 |
| ATA3219 | Atara Biotherapeutics | Preclinical |